Venture Capital case studies, worked step by step
- Cases
- 100
- Traced to a firm
- 33
- Topics
- 13
- Hard
- 30
Topic
All topicsTerm sheets and waterfalls9Company pitch10Portfolio management and follow-ons8Unit economics9Down rounds, distress and runway7Fund economics and LP maths6Market sizing and theses8SaaS metrics and diagnostics9Cap tables and round modelling8Growth equity returns8Diligence and red flags5Exits and secondaries6Early-stage valuation7
Showing 1–5 of 5 · filtered from 100Clear filters
- 010A growth fund owns 14% of Shikharik Consumer and the company lists at Rs 6,000 crore. The fund can sell only part of its stake in the IPO and must hold the rest through a lock-up. What does it actually realise?Growth equityIndia VC
- 046Weekend take-home case: write the investment memo on a Rs 250 crore minority stake in Aushvik Pharma, a speciality generics maker bought at 16x EBITDA, weighing three five-year scenarios, and recommend.Growth equityHealthcare VC
- 067Tulavik Software can grow 40% a year while burning cash or 25% a year while making it. Which plan creates more equity value after four years, counting the cash burned or generated?SaaS-focused VCGrowth equity
- 077Dhaarvik Infratech is offered its Rs 4,000 crore pre-money headline only with a 1.5x liquidation preference and an IPO ratchet that guarantees the fund a 20% IRR. What do the fund and the founders get if the year-four IPO values the company at Rs 3,500, Rs 5,000 or Rs 10,000 crore?Growth equityIndia VC
- 090Danthik Dental plans to buy 40 single-dentist clinics at 5x EBITDA of Rs 60 lakh each, add Rs 15 lakh of EBITDA per clinic through shared procurement, and sell the platform at 14x. How much does multiple arbitrage contribute compared with the operating improvement, and what breaks the plan?Growth equityHealthcare VC
Company names and figures are illustrative.